Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Benita Katzenellenbogen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Disorders

Breast Neoplasms

Physiology

Concepts & Ideas

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
46
Katzenellenbogen, John
15
Sun, Jun
14
Stossi, Fabio
14
Carlson, Kathryn
13
Kraus, Lee
12
Montano, MM
11
Frasor, Jonna
9
Martini, Paolo
8
Ekena, K
8
Greene, Geoffrey
8
Komm, Barry
7
McInerney, EM
7
Sheng, Shubin
6
Lazennec, G
6
Barnett, Daniel

Sign-in to see all Coauthors

Publications

TOP 3
Waibel Michael; Kieser Karen J; Carlson Kathryn E; Stossi Fabio; Katzenellenbogen Benita S; Katzenellenbogen John A
Phenethyl pyridines with non-polar internal substituents as selective ligands for estrogen receptor beta.
Waibel Michael; De Angelis Meri; Stossi Fabio; Kieser Karen J; Carlson Kathryn E; Katzenellenbogen Benita S; Katzenellenbogen John A
Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor beta.
Sengupta Surojeet; Schiff Rachel; Katzenellenbogen Benita S
Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Benita Katzenellenbogen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Waibel Michael; Kieser Karen J; Carlson Kathryn E; Stossi Fabio; Katzenellenbogen Benita S; Katzenellenbogen John A
Phenethyl pyridines with non-polar internal substituents as selective ligands for estrogen receptor beta.
European journal of medicinal chemistry 2009;44(9):3560-70.
2009: Waibel Michael; De Angelis Meri; Stossi Fabio; Kieser Karen J; Carlson Kathryn E; Katzenellenbogen Benita S; Katzenellenbogen John A
Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor beta.
European journal of medicinal chemistry 2009;44(9):3412-24.
2009: Sengupta Surojeet; Schiff Rachel; Katzenellenbogen Benita S
Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
Breast cancer research and treatment 2009;117(2):243-51.
2009: Stossi Fabio; Madak-Erdogan Zeynep; Katzenellenbogen Benita S
Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1.
Molecular and cellular biology 2009;29(7):1749-59.
2009: Achari Yamini; Lu Ting; Katzenellenbogen Benita S; Hart David A
Distinct roles for AF-1 and -2 of ER-alpha in regulation of MMP-13 promoter activity.
Biochimica et biophysica acta 2009;1792(3):211-20.
2009: Zhou Hai-Bing; Carlson Kathryn E; Stossi Fabio; Katzenellenbogen Benita S; Katzenellenbogen John A
Analogs of methyl-piperidinopyrazole (MPP): antiestrogens with estrogen receptor alpha selective activity.
Bioorganic & medicinal chemistry letters 2009;19(1):108-10.
2008: Sheng Shubin; Barnett Daniel H; Katzenellenbogen Benita S
Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells.
Molecular and cellular endocrinology 2008;296(1-2):1-9.
2008: Madak-Erdogan Zeynep; Kieser Karen J; Kim Sung Hoon; Komm Barry; Katzenellenbogen John A; Katzenellenbogen Benita S
Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.
Molecular endocrinology (Baltimore, Md.) 2008;22(9):2116-27.
2008: Alyea Rebecca A; Laurence Stephanie E; Kim Sung H; Katzenellenbogen Benita S; Katzenellenbogen John A; Watson Cheryl S
The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells.
Journal of neurochemistry 2008;106(4):1525-33.
2008: Paulmurugan Ramasamy; Tamrazi Anobel; Katzenellenbogen John A; Katzenellenbogen Benita S; Gambhir Sanjiv S
A human estrogen receptor (ER)alpha mutation with differential responsiveness to nonsteroidal ligands: novel approaches for studying mechanism of ER action.
Molecular endocrinology (Baltimore, Md.) 2008;22(7):1552-64.
2008: Barnett Daniel H; Sheng Shubin; Charn Tze Howe; Waheed Abdul; Sly William S; Lin Chin-Yo; Liu Edison T; Katzenellenbogen Benita S
Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.
Cancer research 2008;68(9):3505-15.
2008: Chang Edmund C; Charn Tze Howe; Park Sung-Hee; Helferich William G; Komm Barry; Katzenellenbogen John A; Katzenellenbogen Benita S
Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.
Molecular endocrinology (Baltimore, Md.) 2008;22(5):1032-43.
2008: Nettles Kendall W; Bruning John B; Gil German; Nowak Jason; Sharma Sanjay K; Hahm Johnnie B; Kulp Kristen; Hochberg Richard B; Zhou Haibing; Katzenellenbogen John A; Katzenellenbogen Benita S; Kim Younchang; Joachmiak Andrzej; Greene Geoffrey L
NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses.
Nature chemical biology 2008;4(4):241-7.
2008: Minutolo Filippo; Bellini Rosalba; Bertini Simone; Carboni Isabella; Lapucci Annalina; Pistolesi Letizia; Prota Giovanni; Rapposelli Simona; Solati Francesca; Tuccinardi Tiziano; Martinelli Adriano; Stossi Fabio; Carlson Kathryn E; Katzenellenbogen Benita S; Katzenellenbogen John A; Macchia Marco
Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta.
Journal of medicinal chemistry 2008;51(5):1344-51.
2008: He Bin; Feng Qin; Mukherjee Atish; Lonard David M; DeMayo Francesco J; Katzenellenbogen Benita S; Lydon John P; O'Malley Bert W
A repressive role for prohibitin in estrogen signaling.
Molecular endocrinology (Baltimore, Md.) 2008;22(2):344-60.
2007: Stender Joshua D; Frasor Jonna; Komm Barry; Chang Ken C N; Kraus W Lee; Katzenellenbogen Benita S
Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation.
Molecular endocrinology (Baltimore, Md.) 2007;21(9):2112-23.
2007: Gowri P Mangala; Sengupta Surojeet; Bertera Suzanne; Katzenellenbogen Benita S
Lipin1 regulation by estrogen in uterus and liver: implications for diabetes and fertility.
Endocrinology 2007;148(8):3685-93.
2007: Zhou Hai-Bing; Nettles Kendall W; Bruning John B; Kim Younchang; Joachimiak Andrzej; Sharma Sanjay; Carlson Kathryn E; Stossi Fabio; Katzenellenbogen Benita S; Greene Geoffrey L; Katzenellenbogen John A
Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligands.
Chemistry & biology 2007;14(6):659-69.
2007: Lin Chin-Yo; Vega Vinsensius B; Thomsen Jane S; Zhang Tao; Kong Say Li; Xie Min; Chiu Kuo Ping; Lipovich Leonard; Barnett Daniel H; Stossi Fabio; Yeo Ailing; George Joshy; Kuznetsov Vladimir A; Lee Yew Kok; Charn Tze Howe; Palanisamy Nallasivam; Miller Lance D; Cheung Edwin; Katzenellenbogen Benita S; Ruan Yijun; Bourque Guillaume; Wei Chia-Lin; Liu Edison T
Whole-genome cartography of estrogen receptor alpha binding sites.
PLoS genetics 2007;3(6):e87.
2007: Zhou Hai-Bing; Sheng Shubin; Compton Dennis R; Kim Younchang; Joachimiak Andrzej; Sharma Sanjay; Carlson Kathryn E; Katzenellenbogen Benita S; Nettles Kendall W; Greene Geoffrey L; Katzenellenbogen John A
Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains.
Journal of medicinal chemistry 2007;50(2):399-403.
2006: Likhite Varsha S; Stossi Fabio; Kim Kyuri; Katzenellenbogen Benita S; Katzenellenbogen John A
Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity.
Molecular endocrinology (Baltimore, Md.) 2006;20(12):3120-32.
2006: Katzenellenbogen Benita S
In memoriam: Jack Gorski (1931-2006).
Molecular endocrinology (Baltimore, Md.) 2006;20(11):2611-2.
2006: Mussi Paola; Liao Lan; Park Seong-Eun; Ciana Paolo; Maggi Adriana; Katzenellenbogen Benita S; Xu Jianming; O'Malley Bert W
Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(45):16716-21.
2006: Chang Edmund C; Frasor Jonna; Komm Barry; Katzenellenbogen Benita S
Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Endocrinology 2006;147(10):4831-42.
2006: Harrington William R; Sengupta Surojeet; Katzenellenbogen Benita S
Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells.
Endocrinology 2006;147(8):3843-50.
2006: Frasor Jonna; Chang Edmund C; Komm Barry; Lin Chin-Yo; Vega Vinsensius B; Liu Edison T; Miller Lance D; Smeds Johanna; Bergh Jonas; Katzenellenbogen Benita S
Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome.
Cancer research 2006;66(14):7334-40.
2006: Stossi Fabio; Likhite Varsha S; Katzenellenbogen John A; Katzenellenbogen Benita S
Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter.
The Journal of biological chemistry 2006;281(24):16272-8.
2006: Harrington William R; Kim Sung Hoon; Funk Cory C; Madak-Erdogan Zeynep; Schiff Rachel; Katzenellenbogen John A; Katzenellenbogen Benita S
Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action.
Molecular endocrinology (Baltimore, Md.) 2006;20(3):491-502.
2006: Mishra Rajesh G; Stanczyk Frank Z; Burry Kenneth A; Oparil Suzanne; Katzenellenbogen Benita S; Nealen Michele L; Katzenellenbogen John A; Hermsmeyer R Kent
Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity.
American journal of physiology. Heart and circulatory physiology 2006;290(1):H295-303.
2005: De Angelis Meri; Stossi Fabio; Waibel Michael; Katzenellenbogen Benita S; Katzenellenbogen John A
Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites.
Bioorganic & medicinal chemistry 2005;13(23):6529-42.
2005: Zhou Hai-Bing; Comninos John S; Stossi Fabio; Katzenellenbogen Benita S; Katzenellenbogen John A
Synthesis and evaluation of estrogen receptor ligands with bridged oxabicyclic cores containing a diarylethylene motif: estrogen antagonists of unusual structure.
Journal of medicinal chemistry 2005;48(23):7261-74.
2005: Frasor Jonna; Danes Jeanne M; Funk Cory C; Katzenellenbogen Benita S
Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(37):13153-7.
2005: Wang Chenguang; Fan Saijun; Li Zhiping; Fu Maofu; Rao Mahadev; Ma Yongxian; Lisanti Michael P; Albanese Chris; Katzenellenbogen Benita S; Kushner Peter J; Weber Barbara; Rosen Eliot M; Pestell Richard G
Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
Cancer research 2005;65(15):6557-67.
2005: Guerini Vittoria; Sau Daniela; Scaccianoce Eugenia; Rusmini Paola; Ciana Paolo; Maggi Adriana; Martini Paolo G V; Katzenellenbogen Benita S; Martini Luciano; Motta Marcella; Poletti Angelo
The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.
Cancer research 2005;65(12):5445-53.
2005: Rai Deshanie; Frolova Antonina; Frasor Jonna; Carpenter Anne E; Katzenellenbogen Benita S
Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells.
Molecular endocrinology (Baltimore, Md.) 2005;19(6):1606-17.
2005: Aghmesheh Morteza; Edwards Lyndal; Clarke Christine L; Byth Karen; Katzenellenbogen Benita S; Russell Pamela J; Friedlander Michael; Tucker Katherine M; de Fazio Anna
Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas.
Gynecologic oncology 2005;97(1):16-25.
2005: Park Seong-Eun; Xu Jianming; Frolova Antonina; Liao Lan; O'Malley Bert W; Katzenellenbogen Benita S
Genetic deletion of the repressor of estrogen receptor activity (REA) enhances the response to estrogen in target tissues in vivo.
Molecular and cellular biology 2005;25(5):1989-99.
2005: De Angelis Meri; Stossi Fabio; Carlson Kathryn A; Katzenellenbogen Benita S; Katzenellenbogen John A
Indazole estrogens: highly selective ligands for the estrogen receptor beta.
Journal of medicinal chemistry 2005;48(4):1132-44.
2005: Montano Monica M; Bianco Nicole R; Deng Huayun; Wittmann Bryan M; Chaplin Laura C; Katzenellenbogen Benita S
Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen.
Frontiers in bioscience : a journal and virtual library 2005;10():1440-61.
2004: Compton Dennis R; Sheng Shubin; Carlson Kathryn E; Rebacz Natalie A; Lee In Young; Katzenellenbogen Benita S; Katzenellenbogen John A
Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
Journal of medicinal chemistry 2004;47(24):5872-93.
2004: Chen Zhilei; Katzenellenbogen Benita S; Katzenellenbogen John A; Zhao Huimin
Directed evolution of human estrogen receptor variants with significantly enhanced androgen specificity and affinity.
The Journal of biological chemistry 2004;279(32):33855-64.
2004: Stossi Fabio; Barnett Daniel H; Frasor Jonna; Komm Barry; Lyttle C Richard; Katzenellenbogen Benita S
Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors.
Endocrinology 2004;145(7):3473-86.
2004: Tsai Houng-Wei; Katzenellenbogen John A; Katzenellenbogen Benita S; Shupnik Margaret A
Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradation.
Endocrinology 2004;145(6):2730-8.
2004: Acevedo Mari Luz; Lee Kathleen C; Stender Joshua D; Katzenellenbogen Benita S; Kraus W Lee
Selective recognition of distinct classes of coactivators by a ligand-inducible activation domain.
Molecular cell 2004;13(5):725-38.
2004: Muthyala Rajeev S; Ju Young H; Sheng Shubin; Williams Lee D; Doerge Daniel R; Katzenellenbogen Benita S; Helferich William G; Katzenellenbogen John A
Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.
Bioorganic & medicinal chemistry 2004;12(6):1559-67.
2004: Katzenellenbogen Benita S; Frasor Jonna
Therapeutic targeting in the estrogen receptor hormonal pathway.
Seminars in oncology 2004;31(1 Suppl 3):28-38.
2004: Frasor Jonna; Stossi Fabio; Danes Jeanne M; Komm Barry; Lyttle C Richard; Katzenellenbogen Benita S
Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells.
Cancer research 2004;64(4):1522-33.
2004: Nettles Kendall W; Sun Jun; Radek James T; Sheng Shubin; Rodriguez Alice L; Katzenellenbogen John A; Katzenellenbogen Benita S; Greene Geoffrey L
Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors.
Molecular cell 2004;13(3):317-27.
2003: Frasor Jonna; Danes Jeanne M; Komm Barry; Chang Ken C N; Lyttle C Richard; Katzenellenbogen Benita S
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.
Endocrinology 2003;144(10):4562-74.
2003: Minutolo Filippo; Antonello Michela; Bertini Simone; Ortore Gabriella; Placanica Giorgio; Rapposelli Simona; Sheng Shubin; Carlson Kathryn E; Katzenellenbogen Benita S; Katzenellenbogen John A; Macchia Marco
Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process.
Journal of medicinal chemistry 2003;46(19):4032-42.
2003: Harrington William R; Sheng Shubin; Barnett Daniel H; Petz Larry N; Katzenellenbogen John A; Katzenellenbogen Benita S
Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
Molecular and cellular endocrinology 2003;206(1-2):13-22.
2003: Frasor Jonna; Barnett Daniel H; Danes Jeanne M; Hess Rex; Parlow Albert F; Katzenellenbogen Benita S
Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus.
Endocrinology 2003;144(7):3159-66.
2003: Martini Paolo G V; Katzenellenbogen Benita S
Modulation of estrogen receptor activity by selective coregulators.
The Journal of steroid biochemistry and molecular biology 2003;85(2-5):117-22.
2003: Muthyala Rajeev S; Sheng Shubin; Carlson Kathryn E; Katzenellenbogen Benita S; Katzenellenbogen John A
Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor.
Journal of medicinal chemistry 2003;46(9):1589-602.
2003: Sun Jun; Katzenellenbogen John A; Zhao Huimin; Katzenellenbogen Benita S
DNA shuffling method for generating estrogen receptor alpha and beta chimeras in yeast.
BioTechniques 2003;34(2):278-80, 282, 284 passim.
2003: Sun Jun; Baudry Jerome; Katzenellenbogen John A; Katzenellenbogen Benita S
Molecular basis for the subtype discrimination of the estrogen receptor-beta-selective ligand, diarylpropionitrile.
Molecular endocrinology (Baltimore, Md.) 2003;17(2):247-58.
2003: Ghosh Usha; Ganessunker Deshanie; Sattigeri Viswajanani J; Carlson Kathryn E; Mortensen Deborah J; Katzenellenbogen Benita S; Katzenellenbogen John A
Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes.
Bioorganic & medicinal chemistry 2003;11(4):629-57.
2003: Rajendran Ramji R; Nye Anne C; Frasor Jonna; Balsara Rashna D; Martini Paolo G V; Katzenellenbogen Benita S
Regulation of nuclear receptor transcriptional activity by a novel DEAD box RNA helicase (DP97).
The Journal of biological chemistry 2003;278(7):4628-38.
2002: Zhou Qing; Nie Rong; Prins Gail S; Saunders Philippa T K; Katzenellenbogen Benita S; Hess Rex A
Localization of androgen and estrogen receptors in adult male mouse reproductive tract.
Journal of andrology 2002;23(6):870-81.
2002: Harris Heather A; Katzenellenbogen John A; Katzenellenbogen Benita S
Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand.
Endocrinology 2002;143(11):4172-7.
2002: Ediger Tracy R; Park Seong-Eun; Katzenellenbogen Benita S
Estrogen receptor inducibility of the human Na+/H+ exchanger regulatory factor/ezrin-radixin-moesin binding protein 50 (NHE-RF/EBP50) gene involving multiple half-estrogen response elements.
Molecular endocrinology (Baltimore, Md.) 2002;16(8):1828-39.
2002: Nye Anne C; Rajendran Ramji R; Stenoien David L; Mancini Michael A; Katzenellenbogen Benita S; Belmont Andrew S
Alteration of large-scale chromatin structure by estrogen receptor.
Molecular and cellular biology 2002;22(10):3437-49.
2002: Shiau Andrew K; Barstad Danielle; Radek James T; Meyers Marvin J; Nettles Kendall W; Katzenellenbogen Benita S; Katzenellenbogen John A; Agard David A; Greene Geoffrey L
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.
Nature structural biology 2002;9(5):359-64.
2002: Rickard David J; Waters Katrina M; Ruesink Terry J; Khosla Sundeep; Katzenellenbogen John A; Katzenellenbogen Benita S; Riggs B Lawrence; Spelsberg Thomas C
Estrogen receptor isoform-specific induction of progesterone receptors in human osteoblasts.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(4):580-92.
2002: Katzenellenbogen Benita S; Katzenellenbogen John A
Biomedicine. Defining the "S" in SERMs.
Science (New York, N.Y.) 2002;295(5564):2380-1.
2002: Kowalski Andrés A; Graddy Logan G; Vale-Cruz Dustin S; Choi Inho; Katzenellenbogen Benita S; Simmen Frank A; Simmen Rosalia C M
Molecular cloning of porcine estrogen receptor-beta complementary DNAs and developmental expression in periimplantation embryos.
Biology of reproduction 2002;66(3):760-9.
2002: Sun Jun; Huang Ying R; Harrington William R; Sheng Shubin; Katzenellenbogen John A; Katzenellenbogen Benita S
Antagonists selective for estrogen receptor alpha.
Endocrinology 2002;143(3):941-7.
2001: Katzenellenbogen B S; Sun J; Harrington W R; Kraichely D M; Ganessunker D; Katzenellenbogen J A
Structure-function relationships in estrogen receptors and the characterization of novel selective estrogen receptor modulators with unique pharmacological profiles.
Annals of the New York Academy of Sciences 2001;949():6-15.
2001: Meyers M J; Sun J; Carlson K E; Marriner G A; Katzenellenbogen B S; Katzenellenbogen J A
Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.
Journal of medicinal chemistry 2001;44(24):4230-51.
2001: Zhou Q; Clarke L; Nie R; Carnes K; Lai L W; Lien Y H; Verkman A; Lubahn D; Fisher J S; Katzenellenbogen B S; Hess R A
Estrogen action and male fertility: roles of the sodium/hydrogen exchanger-3 and fluid reabsorption in reproductive tract function.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(24):14132-7.
2001: Mortensen D S; Rodriguez A L; Carlson K E; Sun J; Katzenellenbogen B S; Katzenellenbogen J A
Synthesis and biological evaluation of a novel series of furans: ligands selective for estrogen receptor alpha.
Journal of medicinal chemistry 2001;44(23):3838-48.
2001: Mortensen D S; Rodriguez A L; Sun J; Katzenellenbogen B S; Katzenellenbogen J A
Furans with basic side chains: synthesis and biological evaluation of a novel series of antagonists with selectivity for the estrogen receptor alpha.
Bioorganic & medicinal chemistry letters 2001;11(18):2521-4.
2001: Waters K M; Rickard D J; Riggs B L; Khosla S; Katzenellenbogen J A; Katzenellenbogen B S; Moore J; Spelsberg T C
Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform.
Journal of cellular biochemistry 2001;83(3):448-62.
2001: Martini P G; Katzenellenbogen B S
Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs.
Endocrinology 2001;142(8):3493-501.
2001: Choi I; Ko C; Park-Sarge O K; Nie R; Hess R A; Graves C; Katzenellenbogen B S
Human estrogen receptor beta-specific monoclonal antibodies: characterization and use in studies of estrogen receptor beta protein expression in reproductive tissues.
Molecular and cellular endocrinology 2001;181(1-2):139-50.
2001: Lazennec G; Thomas J A; Katzenellenbogen B S
Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators.
The Journal of steroid biochemistry and molecular biology 2001;77(4-5):193-203.
2001: Wang C; Fu M; Angeletti R H; Siconolfi-Baez L; Reutens A T; Albanese C; Lisanti M P; Katzenellenbogen B S; Kato S; Hopp T; Fuqua S A; Lopez G N; Kushner P J; Pestell R G
Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity.
The Journal of biological chemistry 2001;276(21):18375-83.
2001: Tedesco R; Thomas J A; Katzenellenbogen B S; Katzenellenbogen J A
The estrogen receptor: a structure-based approach to the design of new specific hormone-receptor combinations.
Chemistry & biology 2001;8(3):277-87.
2001: Stauffer S R; Huang Y R; Aron Z D; Coletta C J; Sun J; Katzenellenbogen B S; Katzenellenbogen J A
Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists.
Bioorganic & medicinal chemistry 2001;9(1):151-61.
2000: Stauffer S R; Coletta C J; Tedesco R; Nishiguchi G; Carlson K; Sun J; Katzenellenbogen B S; Katzenellenbogen J A
Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.
Journal of medicinal chemistry 2000;43(26):4934-47.
2000: Martin M B; Franke T F; Stoica G E; Chambon P; Katzenellenbogen B S; Stoica B A; McLemore M S; Olivo S E; Stoica A
A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I.
Endocrinology 2000;141(12):4503-11.
2000: Katzenellenbogen B S; Choi I; Delage-Mourroux R; Ediger T R; Martini P G; Montano M; Sun J; Weis K; Katzenellenbogen J A
Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
The Journal of steroid biochemistry and molecular biology 2000;74(5):279-85.
2000: Delage-Mourroux R; Martini P G; Choi I; Kraichely D M; Hoeksema J; Katzenellenbogen B S
Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA.
The Journal of biological chemistry 2000;275(46):35848-56.
2000: Ju Y H; Carlson K E; Sun J; Pathak D; Katzenellenbogen B S; Katzenellenbogen J A; Helferich W G
Estrogenic effects of extracts from cabbage, fermented cabbage, and acidified brussels sprouts on growth and gene expression of estrogen-dependent human breast cancer (MCF-7) cells.
Journal of agricultural and food chemistry 2000;48(10):4628-34.
2000: Kraichely D M; Sun J; Katzenellenbogen J A; Katzenellenbogen B S
Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
Endocrinology 2000;141(10):3534-45.
2000: Martini P G; Delage-Mourroux R; Kraichely D M; Katzenellenbogen B S
Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity.
Molecular and cellular biology 2000;20(17):6224-32.
2000: Choi I; Gudas L J; Katzenellenbogen B S
Regulation of keratin 19 gene expression by estrogen in human breast cancer cells and identification of the estrogen responsive gene region.
Molecular and cellular endocrinology 2000;164(1-2):225-37.
2000: Stauffer S R; Sun J; Katzenellenbogen B S; Katzenellenbogen J A
Acyclic amides as estrogen receptor ligands: synthesis, binding, activity and receptor interaction.
Bioorganic & medicinal chemistry 2000;8(6):1293-316.
2000: de Haan G; Chusacultanachai S; Mao C; Katzenellenbogen B S; Shapiro D J
Estrogen receptor-KRAB chimeras are potent ligand-dependent repressors of estrogen-regulated gene expression.
The Journal of biological chemistry 2000;275(18):13493-501.
2000: Stoica A; Katzenellenbogen B S; Martin M B
Activation of estrogen receptor-alpha by the heavy metal cadmium.
Molecular endocrinology (Baltimore, Md.) 2000;14(4):545-53.
2000: Katzenellenbogen B S
Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways.
Journal of the Society for Gynecologic Investigation 2000;7(1 Suppl):S33-7.
2000: Katzenellenbogen B S; Katzenellenbogen J A
Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer.
Breast cancer research : BCR 2000;2(5):335-44.
2000: Katzenellenbogen B S; Montano M M; Ediger T R; Sun J; Ekena K; Lazennec G; Martini P G; McInerney E M; Delage-Mourroux R; Weis K; Katzenellenbogen J A
Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Recent progress in hormone research 2000;55():163-93; discussion 194-5.
1999: Gee A C; Carlson K E; Martini P G; Katzenellenbogen B S; Katzenellenbogen J A
Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Molecular endocrinology (Baltimore, Md.) 1999;13(11):1912-23.
1999: Webb P; Nguyen P; Valentine C; Lopez G N; Kwok G R; McInerney E; Katzenellenbogen B S; Enmark E; Gustafsson J A; Nilsson S; Kushner P J
The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions.
Molecular endocrinology (Baltimore, Md.) 1999;13(10):1672-85.
1999: Chusacultanachai S; Glenn K A; Rodriguez A O; Read E K; Gardner J F; Katzenellenbogen B S; Shapiro D J
Analysis of estrogen response element binding by genetically selected steroid receptor DNA binding domain mutants exhibiting altered specificity and enhanced affinity.
The Journal of biological chemistry 1999;274(33):23591-8.
1999: Meyers M J; Sun J; Carlson K E; Katzenellenbogen B S; Katzenellenbogen J A
Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
Journal of medicinal chemistry 1999;42(13):2456-68.
1999: Ediger T R; Kraus W L; Weinman E J; Katzenellenbogen B S
Estrogen receptor regulation of the Na+/H+ exchange regulatory factor.
Endocrinology 1999;140(7):2976-82.
1999: Lazennec G; Alcorn J L; Katzenellenbogen B S
Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation.
Molecular endocrinology (Baltimore, Md.) 1999;13(6):969-80.
1999: Montano M M; Ekena K; Delage-Mourroux R; Chang W; Martini P; Katzenellenbogen B S
An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(12):6947-52.
1999: Lazennec G; Katzenellenbogen B S
Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
Molecular and cellular endocrinology 1999;149(1-2):93-105.
1999: Sun J; Meyers M J; Fink B E; Rajendran R; Katzenellenbogen J A; Katzenellenbogen B S
Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta.
Endocrinology 1999;140(2):800-4.
1998: McInerney E M; Weis K E; Sun J; Mosselman S; Katzenellenbogen B S
Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimeras.
Endocrinology 1998;139(11):4513-22.
1998: Webb P; Nguyen P; Shinsako J; Anderson C; Feng W; Nguyen M P; Chen D; Huang S M; Subramanian S; McKinerney E; Katzenellenbogen B S; Stallcup M R; Kushner P J
Estrogen receptor activation function 1 works by binding p160 coactivator proteins.
Molecular endocrinology (Baltimore, Md.) 1998;12(10):1605-18.
1998: Montano M M; Jaiswal A K; Katzenellenbogen B S
Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta.
The Journal of biological chemistry 1998;273(39):25443-9.
1998: Clemens J W; Robker R L; Kraus W L; Katzenellenbogen B S; Richards J S
Hormone induction of progesterone receptor (PR) messenger ribonucleic acid and activation of PR promoter regions in ovarian granulosa cells: evidence for a role of cyclic adenosine 3',5'-monophosphate but not estradiol.
Molecular endocrinology (Baltimore, Md.) 1998;12(8):1201-14.
1998: Ekena K; Katzenellenbogen J A; Katzenellenbogen B S
Determinants of ligand specificity of estrogen receptor-alpha: estrogen versus androgen discrimination.
The Journal of biological chemistry 1998;273(2):693-9.
1997: Carlson K E; Choi I; Gee A; Katzenellenbogen B S; Katzenellenbogen J A
Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.
Biochemistry 1997;36(48):14897-905.
1997: Kraus W L; Weis K E; Katzenellenbogen B S
Determinants for the repression of estrogen receptor transcriptional activity by ligand-occupied progestin receptors.
The Journal of steroid biochemistry and molecular biology 1997;63(4-6):175-88.
1997: Lazennec G; Ediger T R; Petz L N; Nardulli A M; Katzenellenbogen B S
Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
Molecular endocrinology (Baltimore, Md.) 1997;11(9):1375-86.
1997: Katzenellenbogen B S; Montano M M; Ekena K; Herman M E; McInerney E M
William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer.
Breast cancer research and treatment 1997;44(1):23-38.
1997: Montano M M; Katzenellenbogen B S
The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(6):2581-6.
1997: Montano M M; Kraus W L; Katzenellenbogen B S
Identification of a novel transferable cis element in the promoter of an estrogen-responsive gene that modulates sensitivity to hormone and antihormone.
Molecular endocrinology (Baltimore, Md.) 1997;11(3):330-41.
1997: Ekena K; Weis K E; Katzenellenbogen J A; Katzenellenbogen B S
Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens.
The Journal of biological chemistry 1997;272(8):5069-75.
1996: McInerney E M; Ince B A; Shapiro D J; Katzenellenbogen B S
A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
Molecular endocrinology (Baltimore, Md.) 1996;10(12):1519-26.
1996: Weis K E; Ekena K; Thomas J A; Lazennec G; Katzenellenbogen B S
Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
Molecular endocrinology (Baltimore, Md.) 1996;10(11):1388-98.
1996: Herman M E; Katzenellenbogen B S
Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
The Journal of steroid biochemistry and molecular biology 1996;59(2):121-34.
1996: McInerney E M; Tsai M J; O'Malley B W; Katzenellenbogen B S
Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(19):10069-73.
1996: McInerney E M; Katzenellenbogen B S
Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation.
The Journal of biological chemistry 1996;271(39):24172-8.
1996: Ekena K; Weis K E; Katzenellenbogen J A; Katzenellenbogen B S
Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding.
The Journal of biological chemistry 1996;271(33):20053-9.
1996: Montano M M; Ekena K; Krueger K D; Keller A L; Katzenellenbogen B S
Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Molecular endocrinology (Baltimore, Md.) 1996;10(3):230-42.
1995: Kraus W L; McInerney E M; Katzenellenbogen B S
Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(26):12314-8.
1995: Schodin D J; Zhuang Y; Shapiro D J; Katzenellenbogen B S
Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness.
The Journal of biological chemistry 1995;270(52):31163-71.
1995: Ince B A; Schodin D J; Shapiro D J; Katzenellenbogen B S
Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors.
Endocrinology 1995;136(8):3194-9.
1995: Montano M M; Müller V; Trobaugh A; Katzenellenbogen B S
The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Molecular endocrinology (Baltimore, Md.) 1995;9(7):814-25.
1995: Katzenellenbogen B S; Montano M M; Le Goff P; Schodin D J; Kraus W L; Bhardwaj B; Fujimoto N
Antiestrogens: mechanisms and actions in target cells.
The Journal of steroid biochemistry and molecular biology 1995;53(1-6):387-93.
1995: Kraus W L; Weis K E; Katzenellenbogen B S
Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors.
Molecular and cellular biology 1995;15(4):1847-57.
1994: Herman M E; Katzenellenbogen B S
Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Cancer research 1994;54(22):5867-74.
1994: Ince B A; Montano M M; Katzenellenbogen B S
Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3',5'-monophosphate and ligands including antiestrogens.
Molecular endocrinology (Baltimore, Md.) 1994;8(10):1397-406.
1994: Aronica S M; Kraus W L; Katzenellenbogen B S
Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(18):8517-21.
1994: Kraus W L; Montano M M; Katzenellenbogen B S
Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene.
Molecular endocrinology (Baltimore, Md.) 1994;8(8):952-69.
1994: Fujimoto N; Katzenellenbogen B S
Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence.
Molecular endocrinology (Baltimore, Md.) 1994;8(3):296-304.
1994: Le Goff P; Montano M M; Schodin D J; Katzenellenbogen B S
Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity.
The Journal of biological chemistry 1994;269(6):4458-66.
1994: Cho H; Aronica S M; Katzenellenbogen B S
Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.
Endocrinology 1994;134(2):658-64.
1993: Katzenellenbogen B S; Bhardwaj B; Fang H; Ince B A; Pakdel F; Reese J C; Schodin D; Wrenn C K
Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems.
The Journal of steroid biochemistry and molecular biology 1993;47(1-6):39-48.
1993: Pakdel F; Le Goff P; Katzenellenbogen B S
An assessment of the role of domain F and PEST sequences in estrogen receptor half-life and bioactivity.
The Journal of steroid biochemistry and molecular biology 1993;46(6):663-72.
1993: Kraus W L; Montano M M; Katzenellenbogen B S
Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters.
Molecular endocrinology (Baltimore, Md.) 1993;7(12):1603-16.
1993: Wrenn C K; Katzenellenbogen B S
Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast.
The Journal of biological chemistry 1993;268(32):24089-98.
1993: Pakdel F; Reese J C; Katzenellenbogen B S
Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
Molecular endocrinology (Baltimore, Md.) 1993;7(11):1408-17.
1993: Ince B A; Zhuang Y; Wrenn C K; Shapiro D J; Katzenellenbogen B S
Powerful dominant negative mutants of the human estrogen receptor.
The Journal of biological chemistry 1993;268(19):14026-32.
1993: Kraus W L; Katzenellenbogen B S
Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.
Endocrinology 1993;132(6):2371-9.
1993: Aronica S M; Katzenellenbogen B S
Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
Molecular endocrinology (Baltimore, Md.) 1993;7(6):743-52.
1993: Cho H; Katzenellenbogen B S
Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Molecular endocrinology (Baltimore, Md.) 1993;7(3):441-52.
1993: Katzenellenbogen B S; Fang H; Ince B A; Pakdel F; Reese J C; Wooge C H; Wrenn C K
William L. McGuire Memorial Symposium. Estrogen receptors: ligand discrimination and antiestrogen action.
Breast cancer research and treatment 1993;27(1-2):17-26.
1992: Reese J C; Wooge C H; Katzenellenbogen B S
Identification of two cysteines closely positioned in the ligand-binding pocket of the human estrogen receptor: roles in ligand binding and transcriptional activation.
Molecular endocrinology (Baltimore, Md.) 1992;6(12):2160-6.
1992: Reese J C; Katzenellenbogen B S
Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-independent transactivation and the actions of antiestrogens.
Molecular and cellular biology 1992;12(10):4531-8.
1992: Wooge C H; Nilsson G M; Heierson A; McDonnell D P; Katzenellenbogen B S
Structural requirements for high affinity ligand binding by estrogen receptors: a comparative analysis of truncated and full length estrogen receptors expressed in bacteria, yeast, and mammalian cells.
Molecular endocrinology (Baltimore, Md.) 1992;6(6):861-9.
1992: Reese J C; Katzenellenbogen B S
Characterization of a temperature-sensitive mutation in the hormone binding domain of the human estrogen receptor. Studies in cell extracts and intact cells and their implications for hormone-dependent transcriptional activation.
The Journal of biological chemistry 1992;267(14):9868-73.
1992: Pakdel F; Katzenellenbogen B S
Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination.
The Journal of biological chemistry 1992;267(5):3429-37.
1991: Reese J C; Katzenellenbogen B S
Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells.
Nucleic acids research 1991;19(23):6595-602.
1991: Cho H S; NG P A; Katzenellenbogen B S
Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines.
Molecular endocrinology (Baltimore, Md.) 1991;5(9):1323-30.
1991: Reese J C; Katzenellenbogen B S
Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands.
The Journal of biological chemistry 1991;266(17):10880-7.
1991: Aronica S M; Katzenellenbogen B S
Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors.
Endocrinology 1991;128(4):2045-52.
1990: Wrenn C K; Katzenellenbogen B S
Cross-linking of estrogen receptor to chromatin in intact MCF-7 human breast cancer cells: optimization and effect of ligand.
Molecular endocrinology (Baltimore, Md.) 1990;4(11):1647-54.
1990: Read L D; Keith D; Slamon D J; Katzenellenbogen B S
Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines.
Cancer research 1990;50(13):3947-51.
1990: Katzenellenbogen B S; Norman M J
Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen.
Endocrinology 1990;126(2):891-8.
1990: Katzenellenbogen B S; Nardulli A M; Read L D
Estrogen regulation of proliferation and hormonal modulation of estrogen and progesterone receptor biosynthesis and degradation in target cells.
Progress in clinical and biological research 1990;322():201-11.
1990: Katzenellenbogen B S
A tribute to Jack Gorski: estrogen receptor model builder and scientific friend to many.
Progress in clinical and biological research 1990;322():1-16.
1989: Harlow K W; Smith D N; Katzenellenbogen J A; Greene G L; Katzenellenbogen B S
Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor.
The Journal of biological chemistry 1989;264(29):17476-85.
1989: Read L D; Greene G L; Katzenellenbogen B S
Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Molecular endocrinology (Baltimore, Md.) 1989;3(2):295-304.
1988: Weaver C A; Springer P A; Katzenellenbogen B S
Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells.
Molecular endocrinology (Baltimore, Md.) 1988;2(10):936-45.
1988: Elliston J F; Katzenellenbogen B S
Comparative analysis of estrogen receptors covalently labeled with an estrogen and an antiestrogen in several estrogen target cells as studied by limited proteolysis.
Journal of steroid biochemistry 1988;29(6):559-69.
1988: Nardulli A M; Katzenellenbogen B S
Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin.
Endocrinology 1988;122(4):1532-40.
1988: Read L D; Snider C E; Miller J S; Greene G L; Katzenellenbogen B S
Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines.
Molecular endocrinology (Baltimore, Md.) 1988;2(3):263-71.
1988: Nardulli A M; Greene G L; O'Malley B W; Katzenellenbogen B S
Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation.
Endocrinology 1988;122(3):935-44.

Sign-in to see more